greeksoup/ stock research
Stock research / United States / PFE / FY2007

Pfizer (PFE) FY2007 results: revenue $48.4 billion

Pfizer Inc. (PFE) reported revenue of $48.4 billion for fiscal 2007, the year ended 31 December 2007. Net income was $8.1 billion, and diluted earnings per share $1.17. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2010.

Revenue
$48.4 billion
FY2007FY2007
Operating margin
n/a
FY2007FY2007
Net income
$8.1 billion
FY2007FY2007
Diluted EPS
$1.17
FY2007FY2007

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2007Last 8 years
Revenue48,418
Cost of revenue11,239
Gross profit37,179
Gross margin76.8%
Research and development8,089
Selling, general and administrative15,626
Pre-tax income9,278
Income tax1,023
Effective tax rate11.0%
Net income8,144
Net margin16.8%
Diluted EPS$1.17
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2007Last 8 years
Operating cash flow13,353
Capital expenditure1,880
Free cash flow11,473
Free cash flow margin23.7%
Cash from investing795
Cash from financing-12,610
Depreciation and amortisation5,200
Share-based compensation437
Buybacks9,994
Dividends paid7,975
Diluted shares, weighted6,939m

Balance sheet

$ millionFY2007Last 8 years
Shareholders' equity65,124
Cash and equivalents3,406

10-K for the year ended 31 December 2007, filed 26 February 2010: the filing.